Illustration of SpaceOAR Hydrogel

Quality of life for prostate cancer patients

                                       

How can a radiopaque perirectal spacer enhance the QoL of your patients?

SpaceOAR Vue™ Hydrogel is an innovation that can improve your patient’s quality of life. The enhanced visibility on a CT scan is designed to help you improve contouring accuracy of the prostate and rectum, potentially leading to more accurate treatment planning when compared to SpaceOAR™ Hydrogel.

What is SpaceOAR Vue Hydrogel?

SpaceOAR Vue Hydrogel is an absorbable hydrogel perirectal spacer that temporarily creates space between the prostate and rectum, designed to reduce the radiation dose delivered to the rectum during prostate cancer radiation therapy. SpaceOAR is naturally absorbed after 3 months and is excreted through the patient's urine leaving no implant behind after 6 months.1

      
Hydrogel Spacing: How?
 
        
             

Designed with the applier in mind

SpaceOAR Hydrogel can be injected with an 18G needle, under general or local anesthesia, facilitating ambulatory care without dependence on operating room availability. It is a straightforward and safe injection: in a Pivotal Trial, there was a 99% placement success rate.2 Both the radiation oncologists and urologists who applied the spacer rated the device’s ease of use as “easy” or “very easy” 98.7% of the time.2 To ensure that you are comfortable using SpaceOAR Vue Hydrogel, Boston Scientific trains all new implanters through its mandated training pathway, providing support of procedures until you are confident in injecting the gel independently.

        Interested in SpaceOAR Vue Hydrogel?
 
 
Contact us
          
What prostate cancer patients say
 
 
Patients treated with SpaceOAR Hydrogel report a higher quality of life after prostate cancer radiation 
treatment and experience minimal adverse side effects.2
    

Access patient information
website

contact us

Visit now

Need more
information?

contact us

Contact us

Learn more about SpaceOAR Vue™ Hydrogel

contact us

Product information

Indications, Safety and Warnings




References

1. Data on file with Boston Scientific.
2. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.

Disclaimer

Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

Top